Metabolism-resistant bradykinin antagonists: development and applications.

Area of Science:

• Physiology
• Pharmacology

Background:

• Bradykinin is crucial in normal and pathological physiology.
• Rapid enzymatic degradation historically hindered the study of bradykinin's functions.

Purpose of the Study:

• To overcome challenges in studying bradykinin due to its degradation.
• To explore the therapeutic potential of bradykinin antagonists.

Main Methods:

• Development of degradation-resistant bradykinin antagonists (peptide and non-peptide).
• Utilizing these antagonists to delineate bradykinin's physiological and pathological roles.

Main Results:

• Effective degradation-resistant antagonists have been developed.
• These antagonists allow for the detailed elucidation of bradykinin's functions.
• Both peptide and non-peptide antagonists are potent, stable, and orally available.

Conclusions:

• Bradykinin antagonists are valuable tools for understanding bradykinin's roles.
• Antagonists offer a promising therapeutic strategy for conditions involving excess bradykinin.
• Future drug development for cancer, inflammation, and trauma is anticipated.